Insider Trading: Catalyst Pharmaceutical Partners Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

2.68USD
23 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$2.68
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,370,416
52-wk High
$3.49
52-wk Low
$1.29

Search Stocks
Biomarin Pharmaceutical Inc Options Exercised: 0
Trade Date: Friday, 7 Dec 2012 Price: 0.75
Title: Beneficial Owner of More than 10% Class Shares Held: 6,666,667
Type Traded: Direct Net Change in Shares This Filing: 5,000,000

Institutional Holders

% Shares Owned: 33.74%
# of Holders: 51
Total Shares Held: 22,665,768
3 Mo. Net Change: 7,500
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1

Officers & Directors

Name Age Since Current Position

Patrick McEnany

66 2006 Chairman of the Board, President, Chief Executive Officer

Alicia Grande

42 2011 Chief Financial Officer, Vice President, Treasurer

Steven Miller

52 2011 Chief Operating Officer, Chief Scientific Officer

David Muth

59 2014 Executive Vice President - Corporate Development

M. Douglas Winship

64 2006 Vice President - Regulatory Operations

Bernardino Mosquera

46 2013 Vice President - Clinical Operations

Charles O'Keeffe

74 2011 Lead Independent Director

Barrett McGrath

2014 Chief Commercial Officer

Philip Coelho

70 2002 Independent Director

Hubert Huckel

82 2006 Independent Director

David Tierney

50 2002 Independent Director

David Connolly

IR Contact Officer
Search Stocks